Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.

Unemo M, Del Rio C, Shafer WM.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0009-2015.

2.

Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.

Edwards JL, Jennings MP, Apicella MA, Seib KL.

Crit Rev Microbiol. 2016 Jan 23:1-14. [Epub ahead of print]

PMID:
26805040
3.

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Drews S, Horsman G, Wylie J, Haldane D, Garceau R, Ratnam S, Wong T, Archibald C, Mulvey MR.

Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.

4.
5.

Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.

Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Nov;53(11):3606-8. doi: 10.1128/JCM.01632-15. Epub 2015 Aug 19.

6.

Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.

Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Jul;53(7):2042-8. doi: 10.1128/JCM.00493-15. Epub 2015 Apr 15.

7.

Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan.

Shigemura K, Osawa K, Miura M, Tanaka K, Arakawa S, Shirakawa T, Fujisawa M.

Antimicrob Agents Chemother. 2015 May;59(5):2695-9. doi: 10.1128/AAC.04320-14. Epub 2015 Feb 23.

8.

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae.

Pettus K, Sharpe S, Papp JR.

Antimicrob Agents Chemother. 2015 Apr;59(4):2443-5. doi: 10.1128/AAC.04127-14. Epub 2015 Jan 26.

10.

Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.

Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, Allen V, Hoang L, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wylie J, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Jan;53(1):191-200. doi: 10.1128/JCM.02589-14. Epub 2014 Nov 5.

11.

Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Unemo M, Shafer WM.

Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. Review.

12.

Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Liu H, Taylor TH Jr, Pettus K, Trees D.

J Clin Microbiol. 2014 May;52(5):1435-40. doi: 10.1128/JCM.02131-13. Epub 2014 Feb 19.

13.

Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.

Yu RX, Yin Y, Wang GQ, Chen SC, Zheng BJ, Dai XQ, Han Y, Li Q, Zhang GY, Chen X.

PLoS One. 2014 Jan 31;9(1):e87849. doi: 10.1371/journal.pone.0087849. eCollection 2014. Review.

14.

Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.

Gose S, Nguyen D, Lowenberg D, Samuel M, Bauer H, Pandori M.

BMC Infect Dis. 2013 Dec 4;13:570. doi: 10.1186/1471-2334-13-570.

15.

Utility of specimens positive for Neisseria gonorrhoeae by the Aptima Combo 2 assay for assessment of strain diversity and antibiotic resistance.

Pabbaraju K, Wong S, Song JJ, Singh AE, Read R, Drews SJ.

J Clin Microbiol. 2013 Dec;51(12):4156-60. doi: 10.1128/JCM.01694-13. Epub 2013 Oct 9.

16.

Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.

Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M; Antibiotic-Resistant Gonorrhea Study Group.

Antimicrob Agents Chemother. 2013 Nov;57(11):5225-32. doi: 10.1128/AAC.01295-13. Epub 2013 Aug 12.

17.

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.

Olsen B, Pham TL, Golparian D, Johansson E, Tran HK, Unemo M.

BMC Infect Dis. 2013 Jan 25;13:40. doi: 10.1186/1471-2334-13-40.

18.

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Unemo M, Nicholas RA.

Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117. Review.

19.

Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.

Hess D, Wu A, Golparian D, Esmaili S, Pandori W, Sena E, Klausner JD, Barry P, Unemo M, Pandori M.

Antimicrob Agents Chemother. 2012 Nov;56(11):5633-41. doi: 10.1128/AAC.00636-12. Epub 2012 Aug 20.

20.

Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.

Goldstein E, Kirkcaldy RD, Reshef D, Berman S, Weinstock H, Sabeti P, Del Rio C, Hall G, Hook EW, Lipsitch M.

Emerg Infect Dis. 2012 Aug;18(8):1290-7. doi: 10.3201/eid1808.111202.

Items per page

Supplemental Content

Write to the Help Desk